Nektar Therapeutics (NKTR) ROE US GAAP (year values)

2020 2021 2022 2022 2023   LTM ?
ROE, % ? -41.3% -77.1% -100.4% -100.4% -210.8%   -138.8%
Changes by years, y/y, % -10pp -36pp -23pp 0pp -110pp    

Nektar Therapeutics. ROE, %

Nektar Therapeutics. ROE, changes, pp

Nektar Therapeutics (NKTR) ROE US GAAP (quarter values)

2023Q1 2023Q2 2023Q3 2023Q4 2024Q1   LTM ?
ROE, % ? -172.2% -155.8% -184.3% -210.8% -138.8%   -138.8%
Changes by years, y/y, % -91pp -41pp -74pp -110pp +33pp    
Changes by quarters, q/q, % -72pp +16pp -28pp -26pp +72pp    

Nektar Therapeutics. ROE, %

Nektar Therapeutics. ROE, changes, pp

Nektar Therapeutics. ROE, changes, pp